CHEK1 and liver cancer: We observed synergistic effects on cell proliferation by XL413 and ATR or CHK1 inhibition (AZD6738 or MK-8776) in all three ATR or CHK1 inhibitor resistant liver cancer cell lines (Fig. 4A–C).